Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

Micke Patrick; Strell Carina; Mattsson Johanna; Martin-Bernabé Alfonso; Brunnström Hans; Huvila Jutta; Sund Malin; Wärnberg Fredrik; Ponten Fredrik; Glimelius Bengt; Hrynchyk Ina; Mauchanski Siarhei; Khelashvili Salome; Garcia-Vicién Gemma; Mollevi David G; Edqvist Per-Henrik; Reilly Aine O; Corvigno Sara; Dahlstrand Hanna; Botling Johan; Segersten Ulrika; Krzyzanowska Agnieszka; Bjartell Anders; Elebro Jacob; Heby Margareta; Lundgren Sebastian; Hedner Charlotta; Borg David; Brändstedt Jenny; Sartor Hanna; Malmström Per-Uno; Johansson Martin; Nodin Björn; Backman Max; Lindskog Cecilia; Jirström Karin; Mezheyeuski Artur

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

Micke Patrick
Strell Carina
Mattsson Johanna
Martin-Bernabé Alfonso
Brunnström Hans
Huvila Jutta
Sund Malin
Wärnberg Fredrik
Ponten Fredrik
Glimelius Bengt
Hrynchyk Ina
Mauchanski Siarhei
Khelashvili Salome
Garcia-Vicién Gemma
Mollevi David G
Edqvist Per-Henrik
Reilly Aine O
Corvigno Sara
Dahlstrand Hanna
Botling Johan
Segersten Ulrika
Krzyzanowska Agnieszka
Bjartell Anders
Elebro Jacob
Heby Margareta
Lundgren Sebastian
Hedner Charlotta
Borg David
Brändstedt Jenny
Sartor Hanna
Malmström Per-Uno
Johansson Martin
Nodin Björn
Backman Max
Lindskog Cecilia
Jirström Karin
Mezheyeuski Artur
Katso/Avaa
Publisher's PDF (986.2Kb)
Lataukset: 

ELSEVIER
doi:10.1016/j.ebiom.2021.103269
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021042821025
Tiivistelmä

Background: The development of a reactive tumour stroma is a hallmark of tumour progression and pronounced tumour stroma is generally considered to be associated with clinical aggressiveness. The variability between tumour types regarding stroma fraction, and its prognosis associations, have not been systematically analysed.

Methods: Using an objective machine-learning method we quantified the tumour stroma in 16 solid cancer types from 2732 patients, representing retrospective tissue collections of surgically resected primary tumours. Image analysis performed tissue segmentation into stromal and epithelial compartment based on pan-cytokeratin staining and autofluorescence patterns.

Findings: The stroma fraction was highly variable within and across the tumour types, with kidney cancer showing the lowest and pancreato-biliary type periampullary cancer showing the highest stroma proportion (median 19% and 73% respectively). Adjusted Cox regression models revealed both positive (pancreato-biliary type periampullary cancer and oestrogen negative breast cancer, HR(95%CI)=0.56(0.34-0.92) and HR (95%CI)=0.41(0.17-0.98) respectively) and negative (intestinal type periampullary cancer, HR(95%CI)=3.59 (1.49-8.62)) associations of the tumour stroma fraction with survival.

Interpretation: Our study provides an objective quantification of the tumour stroma fraction across major types of solid cancer. Findings strongly argue against the commonly promoted view of a general associations between high stroma abundance and poor prognosis. The results also suggest that full exploitation of the prognostic potential of tumour stroma requires analyses that go beyond determination of stroma abundance.

Kokoelmat
  • Rinnakkaistallenteet [27094]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste